key: cord-0788387-zj9plidq
authors: Li Weng, Ying; Naik, Shiv Rakesh; Dingelstad, Nadia; Kalyaanamoorthy, Subha; Ganesan, Aravindhan
title: Molecular dynamics and in silico mutagenesis on the reversible inhibitor-bound SARS-CoV-2 Main Protease complexes reveal the role of a lateral pocket in enhancing the ligand affinity
date: 2020-11-01
journal: bioRxiv
DOI: 10.1101/2020.10.31.363309
sha: dcb108660d80e8bc6fc1c453100d7fd739382c50
doc_id: 788387
cord_uid: zj9plidq

The 2019 novel coronavirus pandemic caused by SARS-CoV-2 remains a serious health threat to humans and a number of countries are already in the middle of the second wave of infection. There is an urgent need to develop therapeutics against this deadly virus. Recent scientific evidences have suggested that the main protease (Mpro) enzyme in SARS-CoV-2 can be an ideal drug target due to its crucial role in the viral replication and transcription processes. Therefore, there are ongoing research efforts to identify drug candidates against SARS-CoV-2 Mpro that resulted in hundreds of X-ray crystal structures of ligand bound Mpro complexes in the protein data bank (PDB) that describe structural details of different chemotypes of fragments binding within different sites in Mpro. In this work, we perform rigorous molecular dynamics (MD) simulation of 62 reversible ligand-Mpro complexes in the PDB to gain mechanistic insights about their interactions at atomic level. Using a total of ~2.25 μs long MD trajectories, we identified and characterized different pockets and their conformational dynamics in the apo Mpro structure. Later, using the published PDB structures, we analyzed the dynamic interactions and binding affinity of small ligands within those pockets. Our results identified the key residues that stabilize the ligands in the catalytic sites and other pockets in Mpro. Our analyses unraveled the role of a lateral pocket in the catalytic site in Mpro that is critical for enhancing the ligand binding to the enzyme. We also highlighted the important contribution from HIS163 in this lateral pocket towards ligand binding and affinity against Mpro through computational mutation analyses. Further, we revealed the effects of explicit water molecules and Mpro dimerization in the ligand association with the target. Thus, comprehensive molecular level insights gained from this work can be useful to identify or design potent small molecule inhibitors against SARS-CoV-2 Mpro.

acid sequence of SARS-CoV-2 M pro shares >95% similarity with that of SARS-CoV M pro (sequence alignment provided in Fig. 1a) . Therefore, there have been significant attraction towards targeting M pro to control SARS-CoV-2 and there are currently hundreds of crystal structures of M pro (either apo or in complex with ligands) reported in the protein data bank (PDB).

Based on the known three-dimensional (3D) structure (in Fig. 1b) , M pro is composed of three domains including the N-terminal domain I (residues 1-101) domain II (residues 102-184) and the C-terminal domain III (residues 201-301) 25 . As seen in the topology diagram of M pro in Fig. 1c , M pro contains 13 β-sheets and 9 α-helices. domains I and II are mainly composed of antiparallel β-sheets, with domain I having seven antiparallel β-sheets (labelled A through G) and

domain II consisting of the other six antiparallel β-sheets (labelled H through M in Fig. 1c ). Unlike these domains, domain III does not have any β-sheet and is composed of a cluster of five α-helices.

domains II and III are linked by a 17-residue long linker loop corresponding to the region PHE185-THR201 (Fig. 1b) . The binding site cleft is formed at the interface of domains I and II with HIS41(from domain I) and CYS145 (from domain II) form a catalytic dyad 26 , which is unlike a catalytic triad in other cysteine and serine proteases 27, 28 . It is proposed that a water molecule at the binding site plays the role of the third residue (in the catalytic triad) and is important in the catalytic mechanism of SARS-COV-2 M pro 25, 29 . A loop formed by CYS44-PRO52 in domain I and the domains II-III linker loop encase the active site as shown in Fig. 1b . Under physiological conditions, M pro exists as a homodimer form, in which two monomers are placed in a perpendicular orientation to each other. In this orientation, the dimer interface is formed by the domain II of the first monomer particularly through residue GLU166 and the N-terminal residues of the second monomer (generally called the "N-finger") 23 enclosing a contact surface area of ~1390 Å 2 21 The N finger from monomer 2 is critical as it closes the catalytic site in monomer A. Further, it is proposed that domain II is crucial in modulating the formation of dimer interface in M pro30 .

Comparison of the structure of SARS-CoV-2 Mpro against the SARS-CoV-1 Mpro (in Fig. 1d (Fig. 1b) . However, as acknowledged by Bzówka et al., despite the high degree of sequence identify between the M pro in SARS-CoV-1 and SARS-CoV-2, it is important to be mindful of the differences in the shape and sizes of their active site and the potential impact of these 12 mutations 25 . The availability of high-resolution crystal structures of Mpro has facilitated a number of in silico-based screening efforts to find suitable molecules from known drugs 18, [31] [32] [33] (for drug repurposing) or from the natural product libraries 29, [34] [35] [36] [37] . Apart from computational studies, the screening against M pro was also carried out through experimental approaches 21, [38] [39] [40] . For example, a screening performed using the fluorescence resonance energy transfer(FRET)-based enzymatic assay 39 While a large number of experimentally resolved structures of ligand M pro complexes are emerging rapidly, it might be important and useful to understand the dynamic interactions of these complexes and to garner any novel molecular level insights from the dynamic process. It is known that molecular dynamics (MD) simulation is a powerful tool to study the dynamic molecular recognition processes in biological systems such as ligand-protein and protein-protein complexes [41] [42] [43] [44] [45] . Earlier, MD has been successful in the discovery of a novel cryptic binding trench in HIV integrase enzyme 46 that eventually led to the development of novel anti-HIV inhibitors such as raltegravir. Therefore, in this work, we use MD to characterize the dynamic interactions of almost all the crystal structures released as of June 10 th , 2020 in PDB (the list is provided in the supplementary Table, ST1 ) and evaluate their binding free energies using the end-point molecular mechanics generalized Born surface area (MM-GBSA) approach. This includes a total of 62 ligand-bound complexes of M pro , whose 3D superposed structure is shown in Fig. 2 23, 30 . However, since the activation process of an enzyme generally takes a much longer time scale than the practical limits of classical MD approach, the simulation of ligand bound to a monomer M pro should be sufficient to capture the overall structural stability of the complexes and evaluate their binding affinity through end-point methods. Nevertheless, we selectively resimulated the complexes with a dimer form of M pro when the ligand is either initially bound at (or at the proximity to) the dimer interface or when the ligand bound in the catalytic site unbound from the site during MD simulation. Each complex was subjected to a 30 ns long MD simulation which resulted in a total of ~2.25µs long MD trajectories. Our results highlight the significance of a lateral pocket in the ligand-Mpro affinity and, in particular, the key role of HIS163 in this pocket through computational mutagenesis. Further, we also calculated the binding free energy of the complexes (with ligand bound at the catalytic site) in the presence of explicit water molecules so as to unravel the effects of water molecules on the ligand-receptor affinity. Thus, our work should be useful to further our knowledge about the interactions of reversible ligand-SARS-CoV-2 M pro complexes at molecular level. complex, the AMBERff14SB force field 47 and the general AMBER force field (GAFF2) 48 were used for the protein and ligand, respectively. The partial charges of the ligand were assigned using the semi-empirical AM1-BCC 49 procedures in antechamber 50 . The missing ligand parameters were obtained using the parmchk2 tools available within the AmberTools 51 . Subsequently, the ligand-M pro complexes were prepared in using tleap program in AMBER18 package 52 by solvating the complex in a cubic box of TIP3P water molecules with a minimum of 12 Å distance between the box boundaries and the closest solute atoms. The solvated systems where subsequently charge neutralized with 150 mM concentration of NaCl counter ions. Thus, the systems were prepared for subsequent MD simulation.

All MD simulations were performed using the AMBER18 molecular dynamics program 52 with pmemd.cuda engine. MD simulation of each ligand-M pro complex was performed in five consecutive stages: (1) energy minimization, (2) NVT heating, (3) NPT equilibration, (4) NPT pre-production simulation, and (5) production simulation. The initial stage of gradient minimization of the system was performed in six rounds. In the first round of minimization, a strong harmonic constraint of 100 kcal mol −1 Å −2 was applied on the solute atoms and 10000 steps of minimization (1000 steps of steepest descent minimization + 9000 steps of conjugate gradient minimization) was performed. The next four rounds of minimization was performed with almost same parameters as the first round except for the harmonic constraints that was reduced as 50>10>5 kcal mol −1 Å −2 in each round. Finally, 20000 steps of energy minimization of the system without any constraints was performed. Following the minimization, each complex was gradually heated to 310K over a duration of 100 ps and, subsequently, equilibrated in four rounds, each being 400 ps long. In the first two rounds of equilibration, positional restraints were applied on the nonhydrogen atoms of the protein residues using restraint force constants of 5 kcal mol −1 Å −2 (first round) and 0.1 kcal mol −1 Å −2 (second round). Following this, the third round of equilibration was performed with a weak restraint of 0.01 kcal mol −1 Å −2 applied to only the backbone atoms of protein residues. Finally, a 400 ps long restraint-free equilibration of the system were carried before proceeding to production simulation. The equilibrated system underwent a 2 ns long preproduction simulation under isothermal-isobaric (NPT) conditions. Following the pre-production run, each complex was subjected to 3 subsequent 10 ns long MD simulation (making a total of 30 ns long MD simulation) using an integration timestep of 2fs. Throughout the simulation, temperature was controlled using the Langevin thermostat 53 and the pressure was kept at 1 bar using the Berendsen barostat 54 . During the production runs, coordinates were stored every 2 ps thereby resulting in a total of 15000 snapshots from a 30ns long MD trajectory. VMD 1.9.3 55 and USCF Chimera 56 were used to visualize the molecular dynamics trajectories. All simulations were performed using the Graham and Cedar GPU clusters available within the ComputeCanada infrastructure. The resulting MD trajectories of the ligand-M pro complexes were processed through the CPPTRAJ tool 57 to generate the root mean square deviation (RMSD) plots and the per-residue root mean square fluctuation or RMSF (for the apo trajectories only).

Following the MD simulation, for each complex, the last 10ns of the MD trajectory was used to compute the binding free energy scores between the ligand and the M pro bound in a complex. For this purpose, we employed the MM-GBSA method 58 with the implicit solvent model of GB-Neck2 (or igb=8) 59 . The snapshots sampled at a regular interval of 10 ps and thus a total of 1000 frames were used to calculate the MM-GBSA energies. The binding free energy (ΔGbind) using the MM-PB(GB)SA can be estimated as,

Here, ΔEMM is the summation of non-bonded and bonded interaction energies 58 . The solvation energy, ΔGsolv, is the sum of the polar and non-polar contributions of solvation, where the polar solvation terms are calculated using a Generalized-Born model or a Poisson-Boltzmann solver and the non-polar terms are computed based on the size of the solvent accessible surface area in the ligand and M pro [58] . However, the last term corresponding to conformational entropy (TΔS) is neglected as it is computationally expensive. It should also be noted that previous studies 60, 61 have shown that incorporating the entropic contribution in the ΔGbind calculations do not assure accurate binding free energy. Therefore, in this work, we calculate only the relative binding free energy, which is often considered as useful in relative ranking of compounds. All MM-GBSA calculations in this study were carried out using the MMPBSA.py script 62 included in the AmberTools 52 . The pairwise decomposition analyses (idecomp=4) using the MD trajectories were also carried out so as to identify the key ligand-residue energetic contributors to the binding free energy of the complexes 63 . module was employed to select the desired number of snapshots and to generate the related topology files for the free energy calculations; whereas, the interface residues were found using the "InterfaceResidues" Pymol script. The NWAT calculation for each system was repeated by increasing the number of explicit water molecules from 0 to 6. All NWAT calculations utilized the shell scripts from Maffucci et al. 64, 65 .

Each of the selected ligand-Mpro complexes were modified by a single point mutation of HIS163 to ALA163 using the 'swapaa' command in UCSF Chimera 56 . The mutated systems were then prepared and subjected to 30 ns long MD simulation as discussed in the above sections for the wild type complexes (in sections 2.1-2.2). However, for the mutated systems, the relative binding free energies were calculated only using the MM-GBSA approach (section 2.3) and the free energies in the presence of explicit water molecules were not computed.

The models of ligand-bound Mpro dimer complexes were constructed using the experimentally resolved 3D structure of a Mpro dimer in the PDB (PDB: 6WTT). This was performed by aligning the ligand-bound Mpro monomer on the structure of Mpro dimer and the duplicate chain after alignment was deleted to obtain the ligand-bound dimer complex. For example, we modeled the dimer structure using the PDB structure of 5RFA, which represents a ligand-bound Mpro monomer complex. This 5RFA structure was aligned against the chain A of the 6WTT structure and it is expected that chains will be 100% aligned as they are essentially the structures from the same sequence. After alignment, the bound-ligand from 5RFA was extracted into the dimer structure (6WTT) and the protein chain of 5RFA was deleted. This resulted in a starting configuration of a ligand-bound Mpro dimer complex. The same process was carried out to build all the 13 dimer complexes in this study. All produces in building the dimer models were performed using the UCSF Chimera. Subsequently, all the dimer complexes were subjected to 30 ns long MD simulation and followed by binding free energy estimation using MM-GBSA method as described above.

In order to understand the dynamics of a SARS-CoV-2 M pro in the absence of a bound ligand, we 67 . In addition, we also identified a critical water-mediated interaction near the active site of Mpro, where a central water-molecule formed a 3-way H-bond network with residues HIS41 (the catalytic residue), ASP187 and HIS164. We noticed that whenever the water molecule at this tri-junction moved out of the binding site during MD, another water molecule entered the site and maintained this H-bond network. This suggests the critical role of water molecules in the stability of the binding site during MD simulation. Moreover, as indicated earlier, it is hypothesized that this water molecule in the binding site could play a role of the third residue in regulating catalysis process in M pro [25, 29] .

Since, the 62 crystal structure complexes studied in this work show ligand binding at different sites other than the actual orthosteric catalytic site in M pro , we explored the dynamics of different pockets in M pro . A protein pocket detection tool, MDpocket 68 , was employed for this purpose.

Using the 30 ns MD trajectory of the apo Mpro, we sampled snapshots at a regular interval of 10 ps from the last 25 ns, thereby, using 2500 snapshots of the enzyme for the pocket analysis. Each suggests that this could be a viable pocket for ligand binding. In consistent with this, we found that ligands (of different size and class) from at least 7 known crystal structures (5RFC, 5RH4, 5RE6, 5RE5, 5RGG, 5RFB, and 6YVF) were found to be bound in this pocket. Pocket 5 is slightly smaller than Pocket 4 but is also quite stable throughout the MD trajectory. This pocket is positioned near the catalytic site (or Pocket 1) between domains I and II, but on the opposite face of the protein.

Four ligands were found to interact with this pocket in the crystal structures (PDBs: 5REI, 5RED, 5RF5, 5RGR). Nevertheless, there is another large pocket of 800 Å 3 , Pocket 6, that is also found between domains I and II and five ligands from the PDB structures of 5RF4, 5RFD, 5RE8, 5RF9, and 5RFJ were found to be interacting at this site. This suggests the stable nature of this pocket under experimental conditions, much like the behaviour observed during our MD simulation. In addition to the well-defined pockets discussed above, we found a huge surface area (dubbed here as pocket 8) of 2,250 Å 3 that was found largely on the surface of domains 2 and 3 ( Thus, our stability analyses highlight the stability and dynamic interactions of the experimentally reported ligand-M pro complexes.

In the earlier section, we discussed the stability of reversible ligands in different pockets in SARS- located at the junction of domain I and II, as these complexes did not show any stable interactions.

In the similar nature, those ligands that egressed from the catalytic pocket also had weak affinity against Mpro and these include the structural complexes of 5REH, 5RF2, 5RF3, 5RF8 and 5R7Z as discussed in the stability analyses. Fig. 5 compares the binding free energies of ligands bound to pocket 3 (Fig. 5a ) and pocket 4 (Fig. 5b) Analysing their binding poses (in Fig. 5a) , the alcohol (-OH) functional group in these compounds bound inside the cavity and was stabilized by the hydrogen bond interactions with TYR239, GLU240 and MET235. Nevertheless, in the binding pose of the ligand ((2R,3R)-1-benzyl-2methylpiperidin-3-ol) that was bound to pocket 3 in Mpro (5REE complex), the phenyl ring was occupying the cavity and the OH group in the piperidin-3-ol moiety was not able to make H-bond interactions with the key residues in this pocket. Consequently, the ligand moved out of the pocket 3 during MD, thereby resulting in a poor affinity of ~-2 kcal/mol (in Fig. 5a ). Earlier we noted that pocket 4 favoured the binding of an acid group as opposed to the amide or amine-based fragments.

In consistent with this interpretation, the binding affinity scores of propanoic acid ligand (5RH4) and benzoinc acid ligand (6YVF) were -17.50 kcal/mol, -15.35 kcal/mol, respectively (Fig. 5b) .

Analyses of their binding poses show that acid groups in these ligands bury themselves in the cavity. In this orientation, they are able to make electrostatic interactions (H-bonds) with the LYS residues in the pocket (LYS88 and LYS90). Energy decomposition analyses revealed that the pairwise interactions of the ligand with key restudies such as HIS80, SER81, LYS88 and LYS90 make significant contributions to the binding affinity of the complexes (Fig. 5b) . Nevertheless, the carbamate-based ligand in the 5RFC structure (Fig. 5b) , a hydrophobic ring deep inside the pocket but has a carboxy group that was placed on the edge of the pocket thereby allowing it to make some electrostatic contacts with SER81 and LYS90. This pose was not favoured as a result, this ligand displayed weaker affinity (-10.63 kcal/mol) when compared to the other acid-based ligands.

Nevertheless, the amide or amine compounds including carboxamide-based (5RGG and 5RE5), acetamide-based (5Re6) and ethanamine (5RFB) ligands were not able to accommodate the cavity in pocket 4, as a result they were not stable in the pocket and made several transient interactions.

The binding free energy scores in Fig.5b does not represent the ligand affinity to one site rather a cumulative effect of interacting with different sites on the surface of M pro during the course of MD. anchored to one of the four segments (in Fig. 6b ) and remained dynamic within the catalytic binding site. Therefore, these complexes had a binding affinity > -15 kcal/mol as seen in Fig. 6a .

For example, the conformational dynamics of the ligand, 6-(ethylamino)pyridine-3-carbonitrile, in the 5R82 structure is clearly described in the supplementary figure, SFig. 8.

We noted that the ligands bound to the catalytic site and stabilized by the interactions with two of the four segments described above exhibited a better binding affinity score that is < -15 kcal/mol (in Fig. 6b ). For example, the bulky compound in the series studied here is N-(4-tert-butylphenyl)-

was co-crystallized with M pro in the pdb structure 6W63. This compound was bound against M pro in a pose (in Fig. 7) , in which the pyridine ring occupied a lateral cavity formed by the 'L1' loop (yellow) and the 'L' β-sheet and formed a stable H-bond with HIS163 residue (Fig. 7c) in this cavity. In addition, the OH groups in this ligand made strong H-bonds with GLU166 and GLY143

(refer to the 2D interaction diagram shown in Fig. 7d ). In addition, the imidazole ring interacted with HIS 41, and the methyl group attached to cyclohexamine moiety made hydrophobic contacts with the 'L2' loop (i.e., the domain II-III linker loop). Pairwise decomposition of interaction energies identified the key residues stabilizing this complex, which include HIS41, ASN142, GLY143, MET165, and GLU166. The interaction of ligands with these key residues contributed at least -3 kcal/mol energy to the binding free energy. Therefore, given the complementary properties between the ligand and the protein in the 6W63 structure, this complex had a high binding affinity score of -34.4 kcal/mol. Unlike the compound in 6w63 complex, the Nalphaacetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide ligand in the PDB structure of 5RG1 is a much linear compound; yet, it displayed strong binding affinity of -36.30 kcal/mol towards M pro .

However, similar to the former, the phenol group in this ligand also filled the lateral pocket ( Fig.   8a ) through H-bonds with the imidazole side-chain of HIS163 residue (Fig. 8c ). In addition, the ligand also formed two strong H-bonds with GLU166 (in Fig. 8c) , and an addition H-bond with GLN189. Decomposition analyses identified HIS163, MET165, GLU166, ARG188, GLN189 as key energetic contributions to the binding free energy (Fig. 8b) . Similar to these compounds, several other pyridine-containing compounds exhibited similar interactions and possesssed a binding affinity value better than -22 kcal/mol (Fig. 6a) . These include ( 

Since our MD and MM-GBSA analyses clearly highlighted the role the lateral pocket in the ligand-Mpro affinity, we analyzed the steric water site in the apo M pro structure. This lateral pocket is composed of residues ASN142, GLY143, SER144, CYS145, HIS163, HIS164, MET165, and GLU166. Our analyses revealed that this pocket, in the absence of a ligand, was occupied by steric water molecules (Fig. 9a) . Next, we analysed the presence of this steric water in the lateral pocket when a ligand was bound in M pro . For example, in the PDB structure of 5RG1, the ligand occupied the lateral pocket and the steric water site was then shifted to the edge of the pocket (Fig. 9a) . This displacement of water allowed the ligand to make stable interactions in the pocket and bind the target with enhanced binding affinity. In the case of ligands that did not fully occupy the lateral pocket, for example PDB 5RGH, the binding affinity was seen to be weaker and, now, the steric water molecule site was again found centered within the lateral pocket (Fig. 9a) . This site likely favours the presence of an electronegative hydrogen bond forming moiety in whose absence the space is occupied by a water molecule that substitutes this role. This evidence supplements the significant role of the lateral pocket in ligand engagement and stronger binding energies.

Our Since the 6W63 ligand is a bulkly compound, the complex can be stabilized in the binding site and lateral pocket by its other important electrostatic and Van der Waals interactions.

We also assessed the effects of mutation on the PDB complex of 5RF7 by building a HIS163ALA mutant model. This complex has a unique 7-azaindole, double-ringed moiety that fits in the lateral pocket. In theWT 5RF7 complex, this moiety formed stable H-bonds with both HIS163 and HIS164. The rest of the ligand was unable to form lasting interactions with the protein residues and oscillated between ASN142/GLY143 and GLU166. In the HIS163ALA mutant, although the HIS163 bond was lost, the strong bond with HIS164 was maintained. In addition, the ligand was positioned so that it interacted stronger with GLU166. The gain of this interaction is evident in the residue decomposition graph in Supplementary figure, SFig. 16. Since the mutated 5RF7 complex can maintain key, stabilizing interactions, specifically in the lateral pocket, its MMGBSA binding affinity was only decreased by -1.076 kcal/mol. Therefore, our computational mutagenesis analyses clearly demonstrate the importance of HIS163 and its role in ligand engagement in SARS-CoV-2 Mpro.

Our MM-GBSA analyses revealed several key interactions that contribute to the binding affinity of the reversible ligands against Mpro. It is known that water molecules play an important role in the catalytic process of Mpro in SARS-CoV-2, as also confirmed by our steric water site analyses.

Therefore, we analyzed the effects of explicit water molecules on the binding free energies of the the presence of a water molecule enhances the affinity, then the polar data points for that system is expected to move inside towards the center. Whereas, if the water molecule did not make any impact, then the polar data points are expected to cluster at the same position. As can be seen in Fig. 8 , we noticed that most of the systems had the impact of explicit water molecules, except in some cases. The complexes represented by the PDB structures 5RHD, 5R7Y, 5R81, 5RGZ, and 5RG1 clearly had a significant impact by the presence of explicit water molecules, as the data points for these systems moved inward with the increase of each water molecule. This suggests that the increase in binding affinity (lower MM-GBSA scores) with increasing numbers of waters.

For example, the maximum impact of water molecules on binding affinity was seen for the 5RHD complex, where the MM-GBSA scores dropped by ~8 kcal/mol (from -13.63 for NWAT=0 to -22.09 for NWAT=6). Analyzing the structures (in Fig. 10b) , it can be noted that the water molecules bridged the bound ligand (1-[4-(methylsulfonyl)phenyl]piperazine) with CYS44 and HIS41 residues during MD. The other water molecules were generally found engaging with the sulfonyl and piperzine groups. Similarly, for the high affinity complexes such as 5RGZ and 5RG1, the inclusion of explicit water molecules further enhanced their affinity towards M pro (Fig. 10a ).

As expected, the water molecules were found to stabilize the electronegative sites such as amide, nitriles, or the hydroxyl groups in the ligands co-crystallized with these complexes (Fig. 10c-d) .

In some other complexes such as these represented by the PDB codes 5RF7, 5RGK, 5RH8, 5RGV, adding one of two water molecules helped to enhance the ligand-enzyme affinity; however, addition of more water molecules did not make any more impact in the affinity. As a result, the MM-GBSA scores for these complexes with NWAT >2 all cluster at one position suggested the saturation in the number of water molecules that can engage inside the catalytic site of M pro . Thus our NWAT-MM-GBSA analyses suggest that upto 2 water molecules could play an important role in the interactions of ligand-M pro in the complexes studied in this work. Nevertheless, we were also able to see that some complexes did not have any impact from the explicit water molecules such as the complexes of 5RGX and 5RE9, as the ligand bound in these complexes were already engaged in optimal interactions with the residues in the pocket, therefore, the water could not contribute to the ligand-protein interactions (supplementary figure, SFig. 17).

As we discussed above some of the ligands bound to the monomer form of M pro did not exhibit stable interactions in MD and egressed the protein during the course of simulation. It is now known that M pro is functional in a dimeric state, where the N-finger of the second monomer interacts with the first monomer chain to close its catalytic site. Therefore, the natural question is if the ligands egressed M pro during our simulation where due to the absence of the involvement of the second chain of M pro . Therefore, in order to address this concern, we analysed the dynamic interactions of the select ligands in the dimeric state of M pro . These include the ligands that were originally bound

(1) within the catalytic site of M pro and unbound during MD, (2) at the dimer interface of M pro (e.g., 5RGQ and 5RFA complexes), and (3) at the proximity to the dimer interface. Using these selection criteria, a total of 13 complexes were selected for evaluation in dimer system. Fig. 11 presents Fig. 12c) .

Further, the amine groups in the ligand made stronger H-bonds with GLU166 (Fig. 11c ) that helped to improve the stability and affinity of this complex. For example, the carboxamide-based ligand (in 5RFA) was bound at the interface of two M pro monomers (Fig. 13a) and remained stable throughout the course of MD simulation, which was not true when it was bound with a monomer enzyme, as described by the ligand RMSDs in Fig 13b. However, within the dimer form, the ligand underwent some structural changes around ~10 ns during MD and remained in a much stable pose that was supported by the interactions of the ligand with the key residues such as MET6, PHE8, ILE152, ASP298 from one M pro monomer, and predominantly SER123 from the other monomer (Fig. 13c ). This pose is described by the 2D interaction diagram shown in Fig. 13d . Since dimerization of M pro is a crucial mechanism for the activity of the enzyme and hence the replication of SARS-CoV-2 enzyme, there is an increasing interest towards disrupting the dimerization of Mpro. Therefore, the molecular level interactions of the ligands at a specific pocket present at the dimer junction identified through earlier X-ray crystal screening efforts 70 and currently studied through our efforts using MD and MM-GBSA analyses could be useful for developing new compounds or identifying known drugs with physicochemical complementarity to this site. Identifying such compounds will allow us to explore the widely acknowledged novel approach of targeting the protease activity in SARS-CoV-2.

The Canada through access to high performance GPU clusters of GRAHAM and Cedar.

Any data related to this work might be available from the corresponding author.

AG and KS contributed to the conception and design of the work. YLW, SRN, and ND contributed equally to carrying out all the modelling, simulation and preparation of figures. All authors contributed equally for the analyses of results, findings and writing the manuscript. All the authors read and approve the final manuscript.

Not applicable.

Not applicable. other key residues such as GLN189 and 166. describe that the ligand was unstable when bound to a monomer of M pro ; however, it was more stable within a dimer condition. This is likely due to its favourable binding in the active site containing pocket where the ligand made stable hydrogen bonds with HIS163 and GLU166 of monomer B thus occupying the lateral pocket that was extensively explored by other ligands part of our set (c). However, it is seen that the N terminal of the second monomer, specifically SER 1, interacts in a hydrophobic manner, which indeed helped in the stable ligand interactions with M pro . The RMSD plots describe that the ligand was unstable when bound to a monomer of M pro ; however, it was more stable within a dimer condition although it unwent some conformational changes at ~10ns before reaching a pleateau indicating the stability of the ligand after this point (b). The energy decomposition analyses (c) identified a number of key residues from both the Mpro monomer chains to stabilze the ligand interactions, as described in the 2D interaction diagram (d). 

WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2

The coronavirus is mutating -does it matter?

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

Time series prediction of COVID-19 by mutation rate analysis using recurrent neural network-based LSTM model

Drug targets for COVID-19 therapeutics: Ongoing global efforts

A rational roadmap for SARS-CoV-2/COVID-19

pharmacotherapeutic research and development: IUPHAR Review 29

Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, united states

Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses

Progress in developing inhibitors of sars-cov-2 3c-like protease. Microorganisms

A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Design of multi-epitope vaccine candidate against SARS-CoV-2: a in-silico study

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation

SARS-CoV-2 vaccines in development

Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Molecular immune pathogenesis and diagnosis of COVID-19

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors

The SARS-CoV-2 transcriptome

Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy

Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates

Structural and evolutionary analysis indicate that the sars-COV-2 mpro is a challenging target for small-molecule inhibitor design

Polymerase chain reaction amplification of bacterial 16S rRNA genes in interstitial cystitis and control patient bladder biopsies

Cysteine proteases: Modes of activation and future prospects as pharmacological targets

Putative inhibitors of SARS-COV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study

The SARS-CoV-2 main protease as drug target

Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors

Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease

Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms

Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences

Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies

Rapid structure-based in-silico virtual screening, molecular dynamics and binding affinity of herbal phyto-molecules against pathogenic macro-protein of SARS-nCoV-2 coronavirus for anti-COVID-19 drug discovery

α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment

GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Molecular dynamics-driven drug discovery: leaping forward with confidence

Atomistic modeling and molecular dynamics analysis of human Ca V 1.2 channel using external electric field and ion pulling simulations

Molecular 'time-machines' to unravel key biological events for drug design

Modeling the human Nav1.5 sodium channel: Structural and mechanistic insights of ion permeation and drug blockade

Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study

Discovery of a Novel Binding Trench in HIV Integrase

ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB

Development and testing of a general Amber force field

Efficient Generation of High-Quality Atomic Charges. AM1-BCC Model: I. Method

Automatic atom type and bond type perception in molecular mechanical calculations

The Amber biomolecular simulation programs

Langevin thermostat for rigid body dynamics

Molecular dynamics with coupling to an external bath

VMD: Visual molecular dynamics

UCSF Chimera -A visualization system for exploratory research and analysis

Software for processing and analysis of molecular dynamics trajectory data

Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations

Improved generalized born solvent model parameters for protein simulations

Effect of atomic charge, solvation, entropy, and ligand protonation state on MM-PB(GB)SA binding energies of HIV protease

Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations

MMPBSA.py: An efficient program for end-state free energy calculations

Computational Study of Protein-Ligand Unbinding for Enzyme Engineering

Improved Computation of Protein-Protein Relative Binding Energies with the Nwat-MMGBSA Method

An efficient implementation of the Nwat-MMGBSA method to rescore docking results in medium-throughput virtual screenings

SARS-CoV-2 Main Protease: A Molecular Dynamics Study

Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography

MDpocket: Open-source cavity detection and characterization on molecular dynamics trajectories

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease 1 2

The authors declared that they have no competing interests.